DCM
DAFNA Capital Management Portfolio holdings
AUM
$362M
This Quarter Return
-10.83%
1 Year Return
-0.48%
3 Year Return
+117.01%
5 Year Return
+181.93%
10 Year Return
+1,483.26%
AUM
$101M
AUM Growth
+$101M
(-15%)
Cap. Flow
-$10.8M
Cap. Flow
% of AUM
-10.73%
Top 10 Holdings %
Top 10 Hldgs %
44.39%
Holding
98
New
22
Increased
10
Reduced
28
Closed
10
Top Buys
| 1 |
NEOS
Neos Therapeutics, Inc
NEOS
|
$1.33M |
| 2 |
Adverum Biotechnologies
ADVM
|
$1.16M |
| 3 |
WINT
Windtree Therapeutics Inc
WINT
|
$814K |
| 4 |
VTAE
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
|
$780K |
| 5 |
Indaptus Therapeutics
INDP
|
$756K |
Top Sells
| 1 |
ZGNX
Zogenix, Inc.
ZGNX
|
$10.6M |
| 2 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$2.03M |
| 3 |
Gyre Therapeutics
GYRE
|
$1.83M |
| 4 |
EVFM
Evofem Biosciences, Inc. Common Stock
EVFM
|
$1.66M |
| 5 |
AtriCure
ATRC
|
$1.33M |
Sector Composition
| 1 | Healthcare | 73.41% |
| 2 | Financials | 0.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NVDQ
26
DELISTED
Novadaq Technologies Inc.
NVDQ
| $1.06M | 1.05% |
101,841
| – | – |
|
|
DRNA
27
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $1.01M | 1.01% |
123,500
+36,700
| +42% | +$301K |
|
28
Ascendis Pharma
ASND
$12.1B
| $942K | 0.93% |
53,241
-40,300
| -43% | -$713K |
|
|
SPNC
29
DELISTED
Spectranetics Corp
SPNC
| $941K | 0.93% |
79,812
+40,000
| +100% | +$472K |
|
|
ZGNX
30
DELISTED
Zogenix, Inc.
ZGNX
| $930K | 0.92% |
68,900
-784,800
| -92% | -$10.6M |
|
31
Johnson & Johnson
JNJ
$426B
| $877K | 0.87% |
9,400
| – | – |
|
|
VTAE
32
DELISTED
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
| $780K | 0.77% |
+70,885
| New | +$780K |
|
|
33
Indaptus Therapeutics
INDP
$6.42M
| $756K | 0.75% |
+135,000
| New | +$756K |
|
34
Abeona Therapeutics
ABEO
$355M
| $736K | 0.73% |
+181,818
| New | +$736K |
|
|
ARNA
35
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $729K | 0.72% |
381,600
+192,600
| +102% | +$368K |
|
36
uniQure
QURE
$940M
| $716K | 0.71% |
35,000
-5,000
| -13% | -$102K |
|
|
CYNA
37
DELISTED
CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA
| $707K | 0.7% |
44,824
-50,000
| -53% | -$789K |
|
|
AKTX
38
Akari Therapeutics
AKTX
$21.2M
| $633K | 0.63% |
+26,390
| New | +$633K |
|
|
ELOS
39
DELISTED
Syneron Medical Ltd
ELOS
| $615K | 0.61% |
85,947
-5,000
| -5% | -$35.8K |
|
|
ALDR
40
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $590K | 0.59% |
+18,000
| New | +$590K |
|
|
RGLS
41
DELISTED
Regulus Therapeutics
RGLS
| $589K | 0.58% |
+90,000
| New | +$589K |
|
42
CareDx
CDNA
$733M
| $567K | 0.56% |
135,927
-9,700
| -7% | -$40.5K |
|
|
CELG
43
DELISTED
Celgene Corp
CELG
| $562K | 0.56% |
+5,200
| New | +$562K |
|
44
Gilead Sciences
GILD
$140B
| $560K | 0.56% |
+5,700
| New | +$560K |
|
|
EXAC
45
DELISTED
Exactech Inc
EXAC
| $551K | 0.55% |
31,636
| – | – |
|
46
Lipocine
LPCN
$15.9M
| $532K | 0.53% |
45,000
-40,000
| -47% | -$473K |
|
|
DERM
47
DELISTED
Dermira, Inc.
DERM
| $525K | 0.52% |
22,500
-34,236
| -60% | -$799K |
|
48
MacroGenics
MGNX
$124M
| $514K | 0.51% |
+24,000
| New | +$514K |
|
|
BLUE
49
DELISTED
bluebird bio
BLUE
| $513K | 0.51% |
6,000
| – | – |
|
50
Amgen
AMGN
$154B
| $512K | 0.51% |
+3,700
| New | +$512K |
|